How were Aphria's earnings last quarter?

Aphria Inc. (NASDAQ:APHA) issued its earnings results on Sunday, April, 11th. The company reported ($1.14) EPS for the quarter, missing the consensus estimate of ($0.04) by $1.10. The firm earned $153.60 million during the quarter, compared to analyst estimates of $172.01 million. Aphria had a negative net margin of 36.10% and a negative trailing twelve-month return on equity of 2.30%. The business's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.02 earnings per share. Read the conference call transcript .

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV) , Alibaba Group (BABA) , Mastercard (MA) , Block (SQ) , Abbott Laboratories (ABT) , Alteryx (AYX) , Big Lots (BIG) and BlackRock (BLK) .

NASDAQ:APHA

Aphria (APHA) Stock Price, News & Analysis

→ Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad)

Free APHA Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $15.38
▼
$15.38
50-Day Range: $13.14
▼
$18.37
52-Week Range: $2.78
▼
$32.29

Volume: N/A
Average Volume: 21.83 million shs
Market Capitalization: $4.87 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Aphria alerts:

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About Aphria Stock (NASDAQ:APHA)

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

Find out more here >>>

APHA Stock News Headlines

September 27, 2023 | benzinga.com

Sheep Ate 600lbs Of Cannabis While Sheltering From A Storm: Here's What They Did Next

September 25, 2023 | markets.businessinsider.com

Ewe Won't Believe It: Greek Sheep's 'Highly' Unconventional Cannabis Greenhouse Adventure

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

June 8, 2023 | markets.businessinsider.com

Tilray CFO Engages Shareholders On Reddit, Addresses Concerns And Company's Growth Strategy

January 3, 2023 | nypost.com

How to bet on Horse Racing: Complete guide to Horse Betting Online

October 14, 2022 | fool.com

Why Owens & Minor Shares Plummeted 32.4% This Week - The Motley Fool

October 11, 2022 | prnewswire.com

The Continued Legalization of Cannabis Creates Need for Intoxication Detection Devices - PR Newswire

October 10, 2022 | finance.yahoo.com

Industrial hemp Market Size-2022 Will Revenue to Cross readjusted size of US$ 3259.5 million by 2028 Top Companies report covers, (It was also one of the primary plants to be rolled into usable fibre 50,000 years ago.) - Yahoo Finance

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

October 8, 2022 | seekingalpha.com

Tilray Brands Stock: Pot Pops Then Drops - Seeking Alpha

October 7, 2022 | law360.com

JPay Founder Says Insider Trading Case Falls Short - Law360

October 4, 2022 | businesswire.com

Global Medical Marijuana Market Trends/Analysis Report 2022: A $65.8 Billion Industry by 2030 - Rapid Adoption of Cannabis in Therapeutic Applications - ResearchAndMarkets.com - Business Wire

October 1, 2022 | prnewswire.com

Global Cannabis Extract Market to Reach $15.5 Billion by 2030 at a CAGR of 20.6% - PR Newswire

September 28, 2022 | businesswire.com

Global Legal Cannabis Market Size, Trends & Analysis Report 2022-2030: Regulatory Scenario, Consumption Pattern, Potential Trade Opportunities, Case Studies, End-users, Competitive Landscape - ResearchAndMarkets.com - Business Wire

September 27, 2022 | globenewswire.com

Cannabis Beverages Market to Reach USD 19,063.58 Million by - GlobeNewswire

September 26, 2022 | finance.yahoo.com

Global Legal Cannabis Market Analysis Report 2022: A $134.4 Billion Industry by 2030, Growing at a CAGR of Over 25% - Yahoo Finance

September 17, 2022 | seekingalpha.com

TLRY Tilray Brands, Inc.

September 14, 2022 | globenewswire.com

With 27.5% CAGR, Global CBD-Infused Beverages Market Size - GlobeNewswire

September 13, 2022 | prnewswire.com

YourWay Cannabis Brands Provides Corporate Update - PR Newswire

September 13, 2022 | businesswire.com

Morganti & Co., Announces that Class Certification Scheduled in the pending shareholder litigation against Auxly Cannabis Group, Inc. - Business Wire

September 11, 2022 | benzinga.com

Joana Scopel

September 10, 2022 | benzinga.com

Tilray Brands (NASDAQ:TLRY) – A Shareholder Lawsuit Stemming From Aphria Could Expose Tilray—Trouble In C - Benzinga

September 7, 2022 | investors.com

Is TLRY Stock A Buy As Germany Gets Closer To Cannabis Legalization? - Investor's Business Daily

September 2, 2022 | seekingalpha.com

TLRY stock gains after debt agreement with JV partner (NASDAQ:TLRY) - Seeking Alpha

September 1, 2022 | law360.com

Canadian Pot Co. Investors Win Class Cert. In Acquisition Suit - Law360

August 31, 2022 | globenewswire.com

Industrial Hemp Market Worth USD 3259.5 million by 2028 | Growth, Size, Shares, Revenue, Types, Applications, Key Players, Top Countries, Growing Factors, Key Dynamics - GlobeNewswire

August 25, 2022 | finance.yahoo.com

Tilray Medical Launches New Products and ‘CannaPoints’ Program to Support Patients Across Canada - Yahoo Finance

See More Headlines

Receive APHA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aphria and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 4/11/2021
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medicinals & Botanicals
Sub-Industry: N/A
Current Symbol: NASDAQ:APHA
CUSIP: N/A
CIK: N/A
Web: aphriainc.com
Phone: (844) 427-4742
Fax: N/A
Employees: 1,200
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.06)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-63,210,000.00
Net Margins: -36.10%
Pretax Margin: N/A
Return on Equity: -2.30%
Return on Assets: -1.66%

Debt

Debt-to-Equity Ratio: 0.25
Current Ratio: 2.36
Quick Ratio: 1.17

Sales & Book Value

Annual Sales: $405.96 million
Price / Sales: 12.00
Cash Flow: $0.09 per share
Price / Cash Flow: 166.43
Book Value: $4.80 per share
Price / Book: 3.20

Miscellaneous

Outstanding Shares: 316,795,000
Free Float: N/A
Market Cap: $4.87 billion
Optionable: Optionable
Beta: 2.67

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Irwin D. Simon (Age 62)
CEO & Chairman
Comp: $5.23M
Mr. Carl A. Merton
Chief Financial Officer
Dr. Christelle Gedeon L.L.B.
Ph.D., Chief Legal Officer & Corp. Sec.
Mr. James R. Meiers
Chief Operating Officer of Aphria Leamington
Ms. Denise Menikheim Faltischek (Age 48)
Chief Strategy Officer & MD of Aphria Germany
Comp: $449.68k
Mr. John B. Sadler
VP of Investor Relations
Mr. Bernard Yeung
Sr. VP of Sales & Marketing
Mr. Victor Neufeld (Age 67)
Special Advisor
Mr. Cole Cacciavillani (Age 66)
Special Advisor
Mr. Randy Daigneau
Sr. VP of Supply Chain

Key Competitors

View All Competitors

APHA Stock Analysis - Frequently Asked Questions

How were Aphria's earnings last quarter?: Aphria Inc. (NASDAQ:APHA) issued its earnings results on Sunday, April, 11th. The company reported ($1.14) EPS for the quarter, missing the consensus estimate of ($0.04) by $1.10. The firm earned $153.60 million during the quarter, compared to analyst estimates of $172.01 million. Aphria had a negative net margin of 36.10% and a negative trailing twelve-month return on equity of 2.30%. The business's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.02 earnings per share.
Read the conference call transcript.
What other stocks do shareholders of Aphria own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV), Alibaba Group (BABA), Mastercard (MA), Block (SQ), Abbott Laboratories (ABT), Alteryx (AYX), Big Lots (BIG) and BlackRock (BLK).

This page (NASDAQ:APHA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Aphria (APHA) Stock Price, News & Analysis

About Aphria Stock (NASDAQ:APHA)

APHA Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

APHA Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info